NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,818 | +29.0% | 18,163 | +24.5% | 0.00% | – |
| Q2 2023 | $8,389 | -37.8% | 14,585 | -24.0% | 0.00% | – |
| Q1 2023 | $13,489 | -81.8% | 19,191 | -16.7% | 0.00% | – |
| Q3 2022 | $74,000 | +469.2% | 23,049 | +600.4% | 0.00% | – |
| Q2 2022 | $13,000 | -18.8% | 3,291 | +12.5% | 0.00% | – |
| Q1 2022 | $16,000 | -38.5% | 2,926 | +51.7% | 0.00% | – |
| Q4 2021 | $26,000 | -13.3% | 1,929 | +15.6% | 0.00% | – |
| Q3 2021 | $30,000 | +7.1% | 1,669 | +3.5% | 0.00% | – |
| Q2 2021 | $28,000 | -12.5% | 1,613 | -0.7% | 0.00% | – |
| Q1 2021 | $32,000 | +433.3% | 1,625 | +364.3% | 0.00% | – |
| Q4 2020 | $6,000 | +20.0% | 350 | +20.7% | 0.00% | – |
| Q3 2020 | $5,000 | +150.0% | 290 | +383.3% | 0.00% | – |
| Q2 2019 | $2,000 | – | 60 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |